What is the most appropriate abortive therapy for a 68-year-old female patient with anxiety?

Abortive Care for Anxiety in a 68-Year-Old Female

I need to clarify that "abortive care" terminology is specific to migraine treatment, not anxiety disorders. The evidence provided focuses heavily on migraine abortive therapy 1, 2, which is not applicable to your patient with anxiety. For anxiety disorders, the appropriate terms are "acute treatment" or "as-needed (PRN) management."

Recommended Approach for Acute Anxiety Management

For acute anxiety episodes in a 68-year-old woman, lorazepam 0.25-0.5 mg orally as needed (maximum 2 mg in 24 hours) is the most appropriate option, with the understanding that this should be used sparingly and only while establishing definitive ongoing treatment with an SSRI.

Rationale and Treatment Algorithm

Step 1: Immediate Symptom Relief (PRN/As-Needed)

• Lorazepam 0.25-0.5 mg orally for acute anxiety episodes
  • Lower dose range specifically recommended for elderly patients 3
  • Can be used sublingually for faster onset
  • Maximum 2 mg per 24 hours in elderly patients
  • Use sparingly to avoid dependence and cognitive impairment

Important Caveat: Benzodiazepines in elderly patients carry significant risks including falls, cognitive impairment, and paradoxical agitation 4. They should be used with extreme caution and only as a bridge to definitive treatment.

Step 2: Establish Definitive Treatment (Primary Management)

First-Line Pharmacotherapy:

• Sertraline or escitalopram are the preferred SSRIs for older adults 4, 5
  • Start with half the usual adult dose
  • Sertraline: begin 25 mg daily, titrate to 50-100 mg
  • Escitalopram: begin 5 mg daily, titrate to 10-20 mg
  • These have the best evidence for efficacy and tolerability in elderly patients

Alternative if sexual side effects are a concern:

• Buspirone 5-10 mg twice daily (for relatively healthy older adults) 4
  • Takes 2-4 weeks for effect
  • No dependence risk
  • Minimal cognitive impairment

Step 3: If First-Line Treatment Inadequate

Second-Line Options:

• Switch to different SSRI or try venlafaxine or duloxetine (SNRIs) 4, 5
• SNRIs have high-quality evidence for anxiety disorders 5

Third-Line Options:

• Pregabalin or gabapentin 4
• These require renal dose adjustment in elderly patients
• Monitor for sedation and falls risk

Critical Considerations for This 68-Year-Old Patient

Medications to AVOID or use with extreme caution:

• Benzodiazepines for chronic use - high risk of falls, cognitive decline, dependence 4, 6
• Hydroxyzine - anticholinergic effects problematic in elderly 4
• Tricyclic antidepressants - cardiovascular and anticholinergic toxicity 6

Age-Specific Concerns:

• Start all medications at half the usual adult dose
• Slower titration schedules (every 2-4 weeks)
• Monitor for drug interactions with other medications
• Assess for underlying medical causes of anxiety (thyroid disease, cardiac conditions, medication side effects) 7
• Screen for comorbid depression (highly prevalent with anxiety) 8

Non-Pharmacological Interventions (Should Be Concurrent)

Cognitive Behavioral Therapy (CBT) is first-line psychotherapy with strongest evidence 5, 9, 10

• Equally effective as medications
• No side effects
• Can be combined with pharmacotherapy for enhanced outcomes
• Internet-based CBT is now an evidence-based option 10

Common Pitfalls to Avoid

1. Do not use benzodiazepines as monotherapy - they mask symptoms without treating the underlying disorder and create dependence risk
2. Do not use acetaminophen or NSAIDs - these are for pain/migraine, not anxiety
3. Do not overlook medical causes - hyperthyroidism, cardiac arrhythmias, medication side effects (steroids, bronchodilators) commonly present as anxiety in elderly 7
4. Do not start at full adult doses - elderly patients require dose reduction due to altered pharmacokinetics

Practical Implementation

Week 1-2:

• Start sertraline 25 mg daily or escitalopram 5 mg daily
• Provide lorazepam 0.25 mg for breakthrough anxiety (limit to 2-3 times weekly maximum)
• Initiate CBT referral

Week 2-4:

• Increase SSRI to therapeutic dose if tolerated
• Monitor for initial activation/increased anxiety (common early SSRI side effect)
• Continue limited PRN benzodiazepine use

Week 4-8:

• Assess response using standardized anxiety scales
• Taper and discontinue benzodiazepine as SSRI takes effect
• Continue CBT

If inadequate response at 8-12 weeks:

• Switch to alternative SSRI or SNRI
• Consider augmentation strategies per Step 3 above

2, 8, 5, 4, 10